TP53 and breast carcinoma: Moreover, SMAR1 leads to reduced migration and invasion in both poorly and highly metastatic breast carcinoma cell lines irrespective of p53 status in both transient and stably SMAR1 transfected cells through downregulation of TGFβ signaling and its target gene expression including CUTL1.